SCLX

Conviction 2HealthcareScan · Mon, Aug 10, 2026

SCLX$6.77-2.59%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 83.19K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Scilex Holding CoBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.scilexholding.com ↗

Price6.77

Change-2.59%

Gap-0.14%

Rel volume1.10×

Avg volume82.76K

Avg $ vol598.39K

SMA 207.29

SMA 507.63

SMA 20010.38

Price vs 50-11.25%

Price vs 200-34.77%

MA stackbearish

50/200 cross—

Supertrendup · 6.41

RSI (14)43

MACD hist-0.03

MACD cross—

Stoch %K / %D31 / 33

ADX (14)19

+DI / −DI16 / 20

RSI divergence—

MACD divergence—

ATR %+9.55%

ADR %8.26%

52w high30.00

52w low5.88

From 52w high-77.43%

Above 52w low+15.14%

New 52w highNo

SqueezeOff

Bollinger width46.15%

%B0.34

Donchian pos14.90%

Donchian high9.74

Donchian low6.25

AVWAP (52w high)13.37

vs AVWAP high-49.35%

AVWAP (52w low)7.85

vs AVWAP low-13.72%

OBV trendDown

Chaikin MF (20)-0.32

Today vs 20d1.10×

Avg vol (14d)83.19K

Avg vol (20d)82.76K

Avg $ vol (20d)598.39K

Market cap—

RS 3m (vs SPY)-19.25%

RS 6m (vs SPY)-25.69%

RS line new highNo

Trend template0/8

Technical rank14.2

1 week+3.20%

1 month-28.59%

3 months-13.43%

6 months-20.26%

1 year-57.34%

YTD-48.28%

P/E-0.16

P/B-0.24

P/S1.95

P/FCF16.02

EPS-36.48

Div yield14.66%

ROE150.09%

ROA-127.39%

Debt/Eq-0.32

Current0.08

EV/EBITDA-0.40

Gross margin415.83%

Net margin—

Rev growth-46.54%

EPS growth-413.76%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value136.45M

Revenue8.61M

Net income-45.65M

Gross profit25.7M

Free cash flow3.68M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out8.49M

Employees34

ListedFri, Nov 11, 2022

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction2 / 100

Pattern quality—

Tech rank14.2 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.95

Support5.83

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SCLX

All disclosures →

No recent disclosed trades by Congress in SCLX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SCLX · 2 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
SCLX Stock Acquisition JV LLC 10% owner · Common stock · 2026-07-03	Dispose	500K	—	2026-07-03	2026-07-07
Ji Henry Exec Chair, CEO and President · Warrant (right to buy) · 2026-04-17	Sell	650K	$100K	2026-04-17	2026-04-20
Ma Stephen Hoi CFO, COO and Secretary · Warrant (right to buy) · 2026-04-17	Buy	650K	$100K	2026-04-17	2026-04-20
Ji Henry Exec Chair, CEO and President · Warrant (right to buy) · 2026-04-16	Buy	3.25M	$500K	2026-04-16	2026-04-20

SEC filings

EDGAR filings in SCLX · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.